Erg Bio
Erg Bio is a California-based biomanufacturing company that licenses and develops Aspire™ Technology, a proprietary low-temperature solvent pretreatment platform converting agricultural and forestry waste into fermentable sugars for synthetic aviation fuel and bio-based chemicals serving aviation, chemicals, and government customers.
- Company typePrivate
- Founded2023
- HeadquartersDublin, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Erg Bio does
Erg Bio is a U.S.-based biomanufacturing company founded in 2023 and headquartered in Dublin, California, that develops and commercializes a proprietary biomass-to-products platform branded as Aspire™ Technology. The technology is a low-temperature solvent pretreatment and catalytic conversion system — exclusively licensed from Lawrence Berkeley National Laboratory's Joint BioEnergy Institute — that processes over 40 types of non-food biomass, including agricultural residues, forestry waste, municipal solid waste, dedicated energy crops, and mixed feedstocks, into fermentable sugars, intermediates, and drop-in fuels. Key technical claims include 90-95% sugar recovery (versus 75-80% for traditional methods), >98-99% solvent recycling, compatibility with commercially available industrial equipment, a proprietary engineered yeast that consolidates cellulase/hemicellulase production and sugar fermentation into a single step, and preservation of high-quality lignin for downstream valorization.
The intended end products are synthetic aviation fuels (SAF), bio-based chemicals, bioplastics, and lignin-derived materials. The business model is B2B enterprise technology licensing combined with future managed-services revenue from integrated biomanufacturing facilities and direct sales of biochemicals/intermediates. The go-to-market combines direct enterprise sales to major fuel and chemical companies with a parallel government-channel strategy targeting the U.S. Department of Defense Distributed Bioindustrial Manufacturing Program (DBIMP) and Department of Energy/EPA Inflation Reduction Act funding programs. The company has secured non-dilutive government awards — including a DoD DBIMP award (announced September 2024 as one of 12 awardees totaling $42M) and a $6M DOE/EPA IRA grant (January 2025) — and closed a $6.5 million seed round in November 2025 led by Azolla Ventures with participation from Chevron Technology Ventures, Freeflow, Plug and Play, and strategic angel investors. As of the available data, Erg Bio operates with a team of approximately 12, is pre-revenue, and is positioned at the pre-pilot demonstration stage of its commercialization roadmap.
Erg Bio firmographics
Firmographics- Name
- Erg Bio
- Legal name
- Erg Bio, Inc.
- Website
- https://ergbio.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Erg Bio is a California-based biomanufacturing company that licenses and develops Aspire™ Technology, a proprietary low-temperature solvent pretreatment platform converting agricultural and forestry waste into fermentable sugars for synthetic aviation fuel and bio-based chemicals serving aviation, chemicals, and government customers.
- Ownership category
- akta.pro rank
Erg Bio industry classification
Industry- Product category
- Biomanufacturing / Biomass Conversion Technology
- NAICS
- Chemical Manufacturing (325), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Biofuel Plant EPC, O&M & Process Technology Providers (EUAAAHAK)
- akta.pro secondary industry
- Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA)
Keywords
Where Erg Bio is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Erg Bio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Technology Licensing: Licensing of Aspire™ Technology to industrial partners for production of synthetic aviation fuels and biochemicals from waste biomass
- Biomanufacturing Facilities: Revenue from integrated biomanufacturing facilities producing fuels and chemicals, with estimated annual local economic impact of ~$100M per facility
- Bio-based Chemicals Production: Production and sale of cost-competitive biochemicals and intermediates derived from biomass conversion for industrial supply chains
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Erg Bio product offering
Product offeringCore offering
Erg Bio develops and licenses Aspire™ Technology, a proprietary low-temperature solvent pretreatment and catalytic platform that converts non-food biomass (agricultural residues, forestry waste, municipal solid waste) into fermentable sugars, high-value intermediates, and drop-in fuels such as synthetic aviation fuel and bio-based chemicals. The company monetizes through technology licensing to industrial partners and is positioned to deploy integrated biomanufacturing facilities producing fuels and chemicals at scale.
Product overview
Erg Bio offers a single unified product platform called Aspire™ Technology, a proprietary low-temperature solvent pretreatment and bioprocessing system that converts waste biomass into fermentable sugars and intermediates for synthetic aviation fuels and critical chemicals. The technology includes an advanced distillable solvent system that recycles over 99% of its components, combined with proprietary engineered yeast that hydrolyzes and ferments sugars, closing the loop from feedstock to finished product.
Differentiator
Problem solved
Functional benefit
Products and services
- Aspire™ Technology
Quantifiable outcome
- 90-95% sugar recovery vs traditional 75-80%
- +5 more outcomes
Companies that use Erg Bio
Customer profileSegments4 records
Ideal customer profiles4 records
Erg Bio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Erg Bio partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- U.S. Environmental Protection AgencycoreJoint DOE/EPA program providing $6M in Inflation Reduction Act funding for demonstration of ASPIRE Feedstock Flexible Biomass Deconstruction and Conversion Technology at pre-pilot scale to advance sustainable aviation fuels.
- Lawrence Berkeley National Laboratory / Joint BioEnergy Institute (LBNL/JBEI)coreErg Bio's core technology is exclusively licensed from the deconstruction and advanced biofuels patent portfolio developed at DOE's Joint BioEnergy Institute, led by Lawrence Berkeley National Laboratory. This partnership provides the foundational IP for the Aspire™ Technology platform.
- IBRL, University of IllinoiscoreResearch and development partnership with the Integrated Bioresource Research Lab at University of Illinois for technology validation and advancement.
- U.S. Department of DefensecoreRecipient of DoD Distributed Bioindustrial Manufacturing Program award. DoD supports domestic bioindustrial manufacturing for national security and defense industrial base resilience. Awards can provide access to up to $100M for facility construction.
- U.S. Department of EnergycoreDOE's Bioenergy Technologies Office provides funding and support for advanced biofuels development. Erg Bio received $6M in Inflation Reduction Act funding for pre-pilot scale demonstration through DOE/EPA joint program.
Scale indicators10 records
Recent moves5 records
Expansion highlights6 records
Erg Bio competitors and assessment
Company assessmentDirect peers
- Sunfire: Sunfire develops power-to-liquid and biomass-to-liquid synthetic fuel technologies for e-fuels and SAF. Competes in the same renewable synthetic-fuels and bio-based chemicals space.
- Velocys: Velocys provides Fischer-Tropsch technology to convert biomass and waste feedstocks into SAF and synthetic fuels. Directly comparable as a biomass-to-fuels process technology company.
- Iogen: Iogen is a long-standing cellulosic-ethanol technology provider with proprietary enzyme and pretreatment platforms. Directly comparable as a biomass-to-fermentable-sugar process technology licensor.
- Gevo: Gevo develops renewable hydrocarbons and sustainable aviation fuel from biomass-derived intermediates. Targets the same aviation-fuel and bio-chemical end markets as Erg Bio with comparable feedstock-flexibility claims.
- Lanzajet: Lanzajet converts ethanol (and potentially cellulosic sugars) into sustainable aviation fuel using Alcohol-to-Jet technology. A direct competitor in the cellulosic-SAF value chain that Erg Bio's Aspire™ platform could supply.
- Aemetis: Aemetis develops renewable fuels including SAF and renewable diesel from biomass feedstocks. A directly comparable renewable-fuels producer targeting the same aviation and chemicals end markets.
- LanzaTech: LanzaTech uses proprietary gas-fermentation technology (comparable to Erg Bio's biomass-to-fuels platform) to convert waste gases and biomass into sustainable aviation fuel and chemicals. Operates a similar licensing/JV business model with major energy and industrial partners.
- Virent (Cargill): Virent (now part of Cargill) developed BioForming technology to convert plant sugars into drop-in biofuels and bio-based chemicals. A direct competitor in biomass-to-drop-in-fuels commercialization.
Broad incumbents
- Praj Industries: Praj Industries is a large incumbent process-technology and EPC provider for ethanol, biofuels, and biorefineries globally. Broad incumbent competing in the biofuel plant and process-technology space where Erg Bio's Aspire™ platform is positioned.
Emerging players
- Bloom Biorenewables: Bloom Biorenewables develops biomass valorization technology to produce specialty chemicals from lignin and cellulose. An emerging player in the same biomass-conversion space with a chemical-products focus comparable to Erg Bio's biochemical revenue stream.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Erg Bio social profiles
Digital presenceErg Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Erg Bio leadership team
Management profileNumber of profiles
Profiles9 records
Erg Bio funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Erg Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Erg Bio
What does Erg Bio do?
Erg Bio develops and licenses Aspire™ Technology, a proprietary low-temperature solvent pretreatment and catalytic platform that converts non-food biomass (agricultural residues, forestry waste, municipal solid waste) into fermentable sugars, high-value intermediates, and drop-in fuels such as synthetic aviation fuel and bio-based chemicals. The company monetizes through technology licensing to industrial partners and is positioned to deploy integrated biomanufacturing facilities producing fuels and chemicals at scale.
Is Erg Bio a public or private company?
Erg Bio is a private company. It is classified as venture growth investor backed and is currently operating.
When was Erg Bio founded?
Erg Bio was founded in 2023. It employs 11 to 50 people.
Where is Erg Bio based?
Erg Bio is headquartered in Dublin, United States, in the North America region.
How does Erg Bio make money?
Three revenue lines are on record. Technology Licensing is the primary driver. The others are biomanufacturing Facilities and bio-based Chemicals Production.
Who are Erg Bio's main competitors?
Direct peers on record are Sunfire, Velocys, Iogen, Gevo, Lanzajet, Aemetis, LanzaTech and Virent (Cargill). Praj Industries is listed as a broad incumbent. Bloom Biorenewables is listed as an emerging player.
Does Erg Bio have an API?
No public API is recorded for Erg Bio.
What industry is Erg Bio in?
Erg Bio's product category is Biomanufacturing / Biomass Conversion Technology. Its primary akta.pro industry code is EUAAAHAK, Biofuel Plant EPC, O&M & Process Technology Providers, with a secondary code of EUAAAIAA, Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol). Its NAICS code is 325 and its SIC code is 8731.